Physician profile
Ryan E Vaccarezza
NPI 1982037040
$1,955.39
in general payments reported to CMS, 2019-2025
19 companies · $171 in 2025
The $171 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $228 · 2022: $476 · 2023: $566 · 2024: $514 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,251.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $443.11 | 2021-2025 | |
| Coloplast Corp | $311.62 | 2021-2023 | Speedicath |
| Antares Pharma, INC. | $178.04 | 2024 | Xyosted |
| Allergan, INC. | $156.56 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $150.75 | 2023-2024 | Bard Urinary Drainage Bag |
| Sumitomo Pharma America, INC. | $149.94 | 2023-2024 | Gemtesa |
| Boston Scientific Corporation | $112.70 | 2022-2024 | Ams 700, Rezum Generator |
| Accord Healthcare, INC. | $82.00 | 2023-2025 | |
| Procept Biorobotics Corporation | $80.98 | 2024-2025 | Aquabeam System |
| Halozyme INC | $50.97 | 2023 | |
| Teleflex LLC | $47.29 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $39.56 | 2022 | |
| Urovant Sciences INC | $32.50 | 2022 | |
| Tolmar, INC. | $28.29 | 2023 | |
| Convatec INC. | $21.85 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ambu INC. | $21.57 | 2025 | |
| Sagent Pharmaceuticals | $17.07 | 2022 | |
| Urogen Pharma, INC. | $16.25 | 2023 | Jelmyto |
| Astellas Pharma US INC | $14.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Vaccarezza listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.